Ovulation-inhibiting properties of Org OD 14

Org OD 14 has recently been shown to be an interesting new steroid for the treatment of menopausal women. In view of the importance of treatment of perimenopausal women, in whom ovulation might occur, the aim of the present study was to assess whether or not Org OD 14, administered orally in a daily dose of 2.5 mg for 21 days, inhibits ovulation. Sixteen healthy female volunteers, aged 20-34 years and with established ovulatory cycles, were studied during a control cycle and a treatment cycle. Daily measurements of the plasma levels of FSH, LH, E2, P and PRL were made. Endometrial specimens were obtained from nine of the volunteers between 23rd and 25th day of both cycles. The criteria for an ovulatory cycle were: (1) mid-cycle FSH, LH and E2 peaks; (2) criteria (1) followed by a rise in the P levels of greater than 10 ng/ml; (3) a luteal phase of at least 12 days; (4) biphasic behaviour of E2; and, (5) secretory endometrium on days 23-25 of the cycle. All control cycles were ovulatory. During the treatment the mid-cycle FSH, LH and E2 peaks disappeared, and P levels remained very low. PRL levels showed an occasional moderate rise in some of the volunteers. Endometrial specimens showed a secretory pattern during the control cycle, and different degrees of proliferation during the treatment cycle in all nine volunteers. It was concluded that Org OD 14 inhibited ovulation in all 16 volunteers.     

Cytosine arabinoside-induced differentiation and killing: unresolved questions

A brief survey of the problems related to leukemic cell differentiation is proposed. The role of cytosine-arabinoside among the differentiation inducers and its potential clinical utility is discussed on the basis of the present literature. The authors report a case of myelomonocytic leukemia which displayed a differentiative response to cytarabine treatment.     

Cytochemistry of mature angiosperm pollen

The problems involved in applying histochemical and cytochemical methods to mature angiosperm pollen for bright light and fluorescence microscopy are discussed. These methods can be used for general examination or to reveal particular structures or groups of substances. The main methods of testing pollen viability and germinability based on stains and semiquantitative methods are also reviewed. The main methods of staining and their applications are summarised.     

Uptake and incorporation of arachidonic acid and of dihomogamma-linolenic acid into tissue lipids in uterine strips isolated from ovariectomized and from ovariectomized-diabetic rats. Effects of 17-beta-estradiol

The uptake of 14C-arachidonic acid (14C-AA) and 14C-dihomogamma-linolenic acid (14C-DGLA) into phospholipids (PLs) and neutral lipids (NLs) in uterine tissue obtained from ovariectomized controls (C) and from ovariectomized-diabetic rats (D) was studied. Uterine strips from D rats incorporate significantly less (P less than 0.05) 14C-AA into PLs than C rats. On the other hand the uptake of 14C-AA into NLs is significantly smaller (P less than 0.05) in uterine tissue from C than from D animals. The estrogenization of the C animals did not modify the incorporation of 14C-AA into PLs or NLs. On the contrary, uterine tissue obtained from D rats treated with 17-beta-estradiol incorporated significantly more labelled AA (P less than 0.05) into PLs and significantly less 14C-AA (P less than 0.05) into NLs than untreated D animals. The incorporation of 14C-DGLA into PLs shows similar pattern in uterine tissue obtained from C and D animals. Estrogenization increased significantly (P less than 0.01) in both cases, the incorporation into PLs. Regarding the incorporation of 14C-DGLA, it was clearly shown that DGLA is taken up significantly more (P less than 0.01) by NLs than by PLs, both in C and D rats. The estrogenization of C and D rats induces a significant decrease in the incorporation of 14C-DGLA into NLs in both experimental groups. The distribution of 14C-AA into the different subfractions of PLs is not uniform.(ABSTRACT TRUNCATED AT 250 WORDS)